申请人:Zhu Guoliang
公开号:US20140142320A1
公开(公告)日:2014-05-22
The invention relates to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, in particular neutral endopeptidase (NEP) inhibitors.